Skip to results
Modify your search
NARROW
1-10 of 10
Authors: Lin Shen
Journal Article
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer Open Access
The Oncologist, Volume 29, Issue 10, October 2024, Pages e1324–e1335, https://doi.org/10.1093/oncolo/oyae087
Published: 30 May 2024
Journal Article
Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro Study Open Access
The Oncologist, Volume 28, Issue 4, April 2023, Pages e191–e197, https://doi.org/10.1093/oncolo/oyac271
Published: 13 February 2023
Journal Article
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study Open Access
The Oncologist, Volume 28, Issue 2, February 2023, Pages 187–e114, https://doi.org/10.1093/oncolo/oyac242
Published: 07 December 2022
Journal Article
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers Open Access
The Oncologist, Volume 29, Issue 6, June 2024, Pages e779–e788, https://doi.org/10.1093/oncolo/oyac080
Published: 10 May 2022
Journal Article
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Efficacy, and Biomarkers Open Access
The Oncologist, Volume 27, Issue 5, May 2022, Pages 342–e383, https://doi.org/10.1093/oncolo/oyab066
Published: 21 April 2022
Journal Article
The Inconsistent and Inadequate Reporting of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials Open Access
The Oncologist, Volume 26, Issue 12, December 2021, Pages e2239–e2246, https://doi.org/10.1002/onco.13940
Published: 31 August 2021
Journal Article
Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE )
Free
The Oncologist, Volume 26, Issue 9, September 2021, Pages e1567–e1580, https://doi.org/10.1002/onco.13826
Published: 03 August 2021
Journal Article
Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment Free
The Oncologist, Volume 20, Issue 6, June 2015, Pages 619–620, https://doi.org/10.1634/theoncologist.2014-0439
Published: 29 April 2015
Journal Article
Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study Free
The Oncologist, Volume 19, Issue 11, November 2014, Pages 1169–1178, https://doi.org/10.1634/theoncologist.2014-0190
Published: 15 September 2014
Journal Article
The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma Free
The Oncologist, Volume 19, Issue 2, February 2014, Pages 173–174, https://doi.org/10.1634/theoncologist.2013-0137
Published: 23 January 2014
